Mutations in KRAS and TP53 are frequently found in lung tumors and lung tissues of smokers [6, 13, 14], and the accumulation of mutations in these and other important oncogenes and tumor suppressor genes are driving forces in the development of lung cancer. This evidence concerns the gene TP53 and lung carcinoma.